Key facts
- It has raised $1.3M.
- Notable investors include Startupbootcamp Holding, Buildit, Commercialization Reactor, Health Founders, Ready2Scale.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for SepsiScan
- ·The full record, as it builds
Funding rounds
No funding rounds for SepsiScan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SepsiScan
Manufacturer of a hyperspectral imaging device intended to provide early detection of sepsis. The company offers a detector that visualizes the oxygen depletion in blood and identifies the area affected by sepsis, enabling ICU staff to make a prompt decision and apply for relevant antibiotics courses, thus, reducing the probability of mortality.
- Sector
- Healthcare
- HQ
- Riga, Latvia
- Founded
- 2022
- Employees
- 5
- Website
- sepsiscan.com/
- Ownership
- Privately Held (backing)
SepsiScan doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SepsiScan shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SepsiScan in its N-PORT filings yet. We sweep new filings monthly.